Facet Biotech

Type: Company
Name: Facet Biotech
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

East Coast Biotech Roundup: Maraganore, Flex, NPS, Retrophin, & More

It’s back to work, back to school, and back to the grind in biotech. One local company inched towards a potential FDA approval, yet its stock is down more than 10 percent. Another biotech came under fire for a big price hike on an old drug. And a new ... [Published Xconomy - Sep 15 2014]
First reported Sep 12 2014 - Updated Sep 12 2014 - 1 reports

AbbVie and Biogen inch toward the FDA with once-a-month MS drug

Partners Biogen Idec ($BIIB) and AbbVie ($ABBV) are touting late-stage results for their new, monthly multiple sclerosis treatment, preparing to hand in regulatory applications next year and contend in a crowded market.The drug, daclizumab, is a subcutaneous ... [Published FierceBiotech - Sep 12 2014]
First reported Aug 20 2014 - Updated Aug 21 2014 - 1 reports

Dermira fetches $51 mln Series C

Dermira , a Redwood City, Calif-based maker of medical dermatology products, has closed $51 million in Series C financing. The investors included Bay City Capital, New Enterprise Associates, Canaan Partners, UCB S.A., Apple Tree Partners, Aisling Capital, ... [Published PE Hub Blog - Aug 20 2014]
First reported Aug 19 2014 - Updated Aug 19 2014 - 1 reports

Dermira : Completes $51 Million Financing and Expands Management Team and Board of Directors

Dermira, a specialty biopharmaceutical company focused on bringinginnovative and differentiated medical dermatology products todermatologists and their patients, today announced that it has completeda $51 million Series C financing. Existing investors ... [Published 4 Traders - Aug 19 2014]

More Content

All (4) | News (3) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
East Coast Biotech Roundup: Maraganore, Flex, N... [Published Xconomy - Sep 15 2014]
AbbVie and Biogen inch toward the FDA with once... [Published FierceBiotech - Sep 12 2014]
Dermira fetches $51 mln Series C [Published PE Hub Blog - Aug 20 2014]
Dermira : Completes $51 Million Financing and E... [Published 4 Traders - Aug 19 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Dermira fetches $51 mln Series C [Published PE Hub Blog - Aug 20 2014]
Dermira , a Redwood City, Calif-based maker of medical dermatology products, has closed $51 million in Series C financing. The investors included Bay City Capital, New Enterprise Associates, Canaan Partners, UCB S.A., Apple Tree Partners, Aisling Capital, ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.